Le Lézard
Classified in: Business

Royce Micro-Cap Trust (NYSE: RMT) as of Jan 31, 2020


NEW YORK, Feb. 26, 2020 /PRNewswire/ --

 

CLOSING PRICES AS OF 01/31/20


NAV

9.43

MKT

8.35

 

AVERAGE ANNUAL TOTAL RETURN AS OF 01/31/20

NAV (%)

MKT (%)

One-Month*

-2.08

-2.22

One-Year

9.38

9.11

Three-Year

7.41

8.78

Five-Year

7.45

7.21

10-Year

11.25

11.98




*Not Annualized

Important Performance and Expense Information
All performance information reflects past performance, is presented on a total return basis, net of the Fund's investment advisory fee, and reflects the reinvestment of distributions. Past performance is no guarantee of future results Current performance may be higher or lower than performance quoted. Returns as of the recent month-end may be obtained at www.roycefunds.com. The market price of the Fund's shares will fluctuate, so that shares may be worth more or less than their original cost when sold.

The Fund normally invests in micro-cap companies, which may involve considerably more risk than investing in larger-cap companies. The Fund's broadly diversified portfolio does not ensure a profit or guarantee against loss.

PORTFOLIO DIAGNOSTICS


Average Market Cap1

$499.4M

Weighted Average P/B2

2.1x

Net Assets

$396.1M

Net Leverage

1.8%

1Geometric Average: This weighted calculation uses each portfolio holding's market cap in a way designed to not skew the effect of very large or small holdings; instead, it aims to better identify the portfolio's center, which Royce believes offers a more accurate measure of average market cap than a simple mean or median.


2Harmonic Average: This weighted calculation evaluates a portfolio as if it were a single stock and measures it overall. It compares the total market value of the portfolio to the portfolio's share in the earnings of its underlying stocks.


The Price-to-Book, or P/B, Ratio is calculated by dividing a company's share price by its book value per share.


Net leverage is the percentage, in excess of 100 %, of the total value of equity type investments, divided by net assets.

Portfolio Composition

TOP 10 POSITIONS

% OF NET ASSETS (SUBJECT TO CHANGE)

Mesa Laboratories

3.4

PAR Technology

2.1

Virgin Galactic Holdings

1.7

FARO Technologies

1.5

Zealand Pharma

1.5

Sandstorm Gold

1.4

Kadant

1.3

Onto Innovation

1.3

Major Drilling Group International

1.3

Seneca Foods

1.2

 

TOP FIVE SECTORS

% OF NET ASSETS (SUBJECT TO CHANGE)

Industrials

20.8

Information Technology

19.8

Health Care

15.4

Financials

12.1

Consumer Discretionary

11.5

Recent Developments
Royce Micro-Cap Trust, Inc. is a closed-end diversified investment company whose shares of Common Stock (RMT) are listed and traded on the New York Stock Exchange. The Fund's investment goal is long-term capital growth, which it seeks by investing primarily in equity securities of companies that, at the time of investment, have market capitalization of $1 billion or less.

Daily net asset values (NAVs) for Royce Micro-Cap Trust, Inc. are now available on our website and online through most ticker symbol lookup services and on broker terminals under the symbol XOTCX. For more information, please call The Royce Funds at (800) 221-4268 or visit www.royceinvest.com.

An investor in Royce Micro-Cap Trust should consider the Fund's investment goals, risks, fees, and expenses carefully before investing.

Important Disclosure Information
Closed-End Funds are registered investment companies whose shares of common stock may trade at a discount to their net asset value. Shares of each Fund's common stock are also subject to the market risks of investing in the underlying portfolio securities held by the Fund. Royce Fund Services, LLC. ("RFS") is a member of FINRA and has filed this material with FINRA on behalf of each Fund. RFS does not serve as a distributor or as an underwriter to the closed-end funds.

 

SOURCE Royce Micro-Cap Trust


These press releases may also interest you

at 19:14
Kadestone Capital Corp. ("Kadestone" or the "Company") , a vertically integrated property company today announced its financial results for the year ended December 31, 2023....

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:54
Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Autodesk, Inc. ("Autodesk" or "the Company") and certain of its officers....

at 18:54
Cliffside Capital Ltd. ("Cliffside" or the "Company")  is pleased to announce financial results for the year ended December 31, 2023. The Company reported the following for 2023 compared with the prior year: Decline in gross finance receivables by...

at 18:47
The Korean Cultural Center New York (KCCNY), a branch of the Ministry of Culture, Sports and Tourism of the Republic of Korea, is proud to present a special exhibition "Whanki in New York," from May 2 to June 13, 2024. This exhibition commemorates...



News published on and distributed by: